dacarbazine has been researched along with Hepatitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kolarović, J; Lalić-Popović, M; Lalošević, D; Mikov, M; Milijašević, B; Stefanović, D; Tomić, Z | 1 |
Bronder, E; Garbe, E; Herbst, H; Kauffmann, W; Klimpel, A; Orzechowski, HD; Sarganas, G; Thomae, M | 1 |
1 review(s) available for dacarbazine and Hepatitis
Article | Year |
---|---|
Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.
Topics: Adverse Drug Reaction Reporting Systems; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Cholestasis; Dacarbazine; Glioblastoma; Hepatitis; Humans; Male; Middle Aged; Prognosis; Temozolomide; United States; United States Food and Drug Administration | 2012 |
1 other study(ies) available for dacarbazine and Hepatitis
Article | Year |
---|---|
Acute toxic effects of single dose dacarbazine: hematological and histological changes in an animal model.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Cricetinae; Dacarbazine; Dose-Response Relationship, Drug; Fibrosarcoma; Hematologic Diseases; Hepatitis; Humans; Male; Pneumonia; Treatment Outcome | 2014 |